Barbara Ann Dworetzky, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Seizures | 40 | 2023 | 2859 | 4.420 |
Why?
|
Psychophysiologic Disorders | 14 | 2021 | 228 | 4.170 |
Why?
|
Epilepsy | 47 | 2023 | 3310 | 3.710 |
Why?
|
Conversion Disorder | 14 | 2023 | 205 | 3.070 |
Why?
|
Somatoform Disorders | 8 | 2019 | 423 | 2.690 |
Why?
|
Electroencephalography | 44 | 2022 | 6150 | 1.630 |
Why?
|
Anticonvulsants | 21 | 2017 | 1916 | 1.180 |
Why?
|
Death, Sudden | 8 | 2022 | 302 | 1.000 |
Why?
|
Epilepsies, Partial | 8 | 2016 | 436 | 0.870 |
Why?
|
Status Epilepticus | 8 | 2016 | 444 | 0.860 |
Why?
|
Monitoring, Physiologic | 7 | 2015 | 1738 | 0.770 |
Why?
|
Sleep Apnea, Central | 2 | 2018 | 84 | 0.730 |
Why?
|
Psychotherapy | 6 | 2019 | 1643 | 0.720 |
Why?
|
Epilepsy, Generalized | 3 | 2015 | 174 | 0.550 |
Why?
|
Aphasia | 3 | 2013 | 179 | 0.550 |
Why?
|
Nervous System Diseases | 4 | 2023 | 1622 | 0.540 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2016 | 45 | 0.540 |
Why?
|
Implantable Neurostimulators | 1 | 2016 | 77 | 0.520 |
Why?
|
Dissociative Disorders | 2 | 2021 | 231 | 0.510 |
Why?
|
Prone Position | 2 | 2021 | 194 | 0.510 |
Why?
|
Neurology | 3 | 2023 | 763 | 0.510 |
Why?
|
Heart Arrest | 4 | 2020 | 1470 | 0.500 |
Why?
|
Psychopathology | 1 | 2017 | 409 | 0.490 |
Why?
|
Epilepsy, Complex Partial | 2 | 2011 | 62 | 0.490 |
Why?
|
Patient Compliance | 3 | 2019 | 2684 | 0.480 |
Why?
|
Vagus Nerve Stimulation | 1 | 2016 | 199 | 0.440 |
Why?
|
Epilepsy, Temporal Lobe | 2 | 2013 | 403 | 0.430 |
Why?
|
Personality | 1 | 2015 | 552 | 0.410 |
Why?
|
Malformations of Cortical Development | 1 | 2013 | 200 | 0.390 |
Why?
|
Videotape Recording | 2 | 2010 | 352 | 0.380 |
Why?
|
Brain Waves | 4 | 2018 | 401 | 0.380 |
Why?
|
Triazines | 6 | 2017 | 315 | 0.380 |
Why?
|
Premenstrual Syndrome | 1 | 2011 | 109 | 0.380 |
Why?
|
Magnetoencephalography | 6 | 2013 | 623 | 0.370 |
Why?
|
Adult | 64 | 2020 | 214055 | 0.370 |
Why?
|
Cerebral Hemorrhage | 3 | 2018 | 2647 | 0.360 |
Why?
|
Women | 1 | 2011 | 230 | 0.350 |
Why?
|
Autonomic Nervous System | 1 | 2015 | 671 | 0.350 |
Why?
|
Arrhythmias, Cardiac | 2 | 2010 | 2268 | 0.350 |
Why?
|
Tachycardia | 4 | 2014 | 619 | 0.340 |
Why?
|
Contraceptives, Oral | 1 | 2011 | 564 | 0.340 |
Why?
|
Radiotherapy | 1 | 2016 | 1533 | 0.330 |
Why?
|
Menarche | 1 | 2011 | 516 | 0.330 |
Why?
|
Interprofessional Relations | 1 | 2015 | 1011 | 0.330 |
Why?
|
Emergencies | 1 | 2015 | 1170 | 0.320 |
Why?
|
Emotions | 2 | 2019 | 2661 | 0.310 |
Why?
|
Humans | 105 | 2023 | 744343 | 0.300 |
Why?
|
Middle Aged | 58 | 2020 | 213383 | 0.300 |
Why?
|
Female | 70 | 2023 | 380194 | 0.290 |
Why?
|
Brain | 15 | 2022 | 26385 | 0.290 |
Why?
|
Consciousness Disorders | 1 | 2010 | 418 | 0.260 |
Why?
|
Sleep | 2 | 2018 | 4623 | 0.260 |
Why?
|
Caffeine | 1 | 2009 | 699 | 0.250 |
Why?
|
Brain Neoplasms | 3 | 2016 | 8863 | 0.250 |
Why?
|
Male | 63 | 2020 | 350118 | 0.250 |
Why?
|
Heart Rate | 2 | 2015 | 4091 | 0.240 |
Why?
|
Cerebral Cortex | 4 | 2016 | 5708 | 0.240 |
Why?
|
Insurance, Health | 1 | 2016 | 2494 | 0.230 |
Why?
|
Patient Care Team | 1 | 2015 | 2531 | 0.230 |
Why?
|
Movement Disorders | 2 | 2019 | 445 | 0.230 |
Why?
|
Emergency Service, Hospital | 4 | 2019 | 7659 | 0.230 |
Why?
|
Young Adult | 24 | 2019 | 56430 | 0.230 |
Why?
|
Menstrual Cycle | 3 | 2012 | 551 | 0.220 |
Why?
|
Prospective Studies | 18 | 2022 | 53288 | 0.220 |
Why?
|
Primary Dysautonomias | 1 | 2022 | 29 | 0.220 |
Why?
|
Awareness | 2 | 2019 | 640 | 0.220 |
Why?
|
Quality of Life | 6 | 2019 | 12804 | 0.210 |
Why?
|
Diagnosis, Differential | 8 | 2021 | 12959 | 0.210 |
Why?
|
Acetamides | 2 | 2016 | 249 | 0.200 |
Why?
|
Fatigue Syndrome, Chronic | 1 | 2023 | 214 | 0.200 |
Why?
|
Monitoring, Ambulatory | 2 | 2017 | 355 | 0.200 |
Why?
|
Video Recording | 3 | 2012 | 949 | 0.190 |
Why?
|
Healthcare Disparities | 1 | 2016 | 3158 | 0.190 |
Why?
|
Treatment Outcome | 18 | 2021 | 63114 | 0.190 |
Why?
|
Occupational Therapy | 1 | 2022 | 134 | 0.180 |
Why?
|
Circadian Rhythm | 1 | 2012 | 2624 | 0.180 |
Why?
|
Pacemaker, Artificial | 3 | 2018 | 816 | 0.170 |
Why?
|
Therapeutic Equivalency | 2 | 2017 | 141 | 0.170 |
Why?
|
Progesterone | 3 | 2012 | 776 | 0.170 |
Why?
|
Cognition Disorders | 1 | 2013 | 4043 | 0.160 |
Why?
|
Valproic Acid | 3 | 2016 | 445 | 0.160 |
Why?
|
Retrospective Studies | 18 | 2023 | 77449 | 0.150 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2019 | 6038 | 0.150 |
Why?
|
Alcohol Drinking | 1 | 2009 | 3966 | 0.140 |
Why?
|
Analysis of Variance | 5 | 2017 | 6365 | 0.140 |
Why?
|
General Adaptation Syndrome | 1 | 2016 | 6 | 0.140 |
Why?
|
Depersonalization | 1 | 2016 | 39 | 0.140 |
Why?
|
Nerve Net | 3 | 2014 | 2174 | 0.140 |
Why?
|
Mass Media | 1 | 2019 | 305 | 0.140 |
Why?
|
Anxiety | 3 | 2021 | 4297 | 0.140 |
Why?
|
Semantics | 3 | 1991 | 584 | 0.140 |
Why?
|
Personality Tests | 1 | 2015 | 83 | 0.140 |
Why?
|
Aged | 27 | 2020 | 163280 | 0.130 |
Why?
|
Piracetam | 1 | 2016 | 87 | 0.130 |
Why?
|
Deep Brain Stimulation | 1 | 2023 | 748 | 0.130 |
Why?
|
Clonazepam | 1 | 2015 | 136 | 0.130 |
Why?
|
Single-Blind Method | 1 | 2019 | 1590 | 0.130 |
Why?
|
Medical Records | 2 | 2011 | 1413 | 0.130 |
Why?
|
Parasomnias | 1 | 2014 | 26 | 0.130 |
Why?
|
Aged, 80 and over | 15 | 2019 | 57776 | 0.120 |
Why?
|
Lorazepam | 1 | 2015 | 145 | 0.120 |
Why?
|
Health Services | 1 | 2000 | 758 | 0.120 |
Why?
|
Drugs, Generic | 2 | 2017 | 421 | 0.120 |
Why?
|
Hypothermia, Induced | 1 | 2020 | 752 | 0.120 |
Why?
|
Sexual Dysfunction, Physiological | 2 | 2010 | 360 | 0.120 |
Why?
|
Adolescent | 20 | 2019 | 85781 | 0.120 |
Why?
|
Artifacts | 3 | 2011 | 1904 | 0.120 |
Why?
|
Luteal Phase | 2 | 2011 | 147 | 0.120 |
Why?
|
Periodicity | 1 | 2015 | 363 | 0.120 |
Why?
|
Follicular Phase | 2 | 2011 | 153 | 0.120 |
Why?
|
Midazolam | 1 | 2015 | 270 | 0.110 |
Why?
|
Trail Making Test | 1 | 2013 | 57 | 0.110 |
Why?
|
Death, Sudden, Cardiac | 2 | 2013 | 1541 | 0.110 |
Why?
|
Galvanic Skin Response | 1 | 2015 | 349 | 0.110 |
Why?
|
Drug Substitution | 1 | 2016 | 281 | 0.110 |
Why?
|
Coma | 1 | 2016 | 475 | 0.110 |
Why?
|
Hospital Units | 1 | 2013 | 141 | 0.110 |
Why?
|
Smoking | 1 | 2009 | 8987 | 0.110 |
Why?
|
Health Status | 2 | 2009 | 4034 | 0.100 |
Why?
|
Narcolepsy | 1 | 2014 | 195 | 0.100 |
Why?
|
Temporal Lobe | 2 | 2010 | 1670 | 0.100 |
Why?
|
Follow-Up Studies | 7 | 2019 | 39050 | 0.100 |
Why?
|
Veterans | 1 | 2005 | 2519 | 0.100 |
Why?
|
Polysomnography | 2 | 2016 | 1776 | 0.100 |
Why?
|
Comorbidity | 4 | 2016 | 10388 | 0.100 |
Why?
|
Functional Laterality | 3 | 2015 | 2290 | 0.100 |
Why?
|
Unnecessary Procedures | 1 | 2015 | 432 | 0.100 |
Why?
|
Memory | 1 | 2001 | 2174 | 0.100 |
Why?
|
Mood Disorders | 1 | 2017 | 1106 | 0.090 |
Why?
|
Sleep Stages | 1 | 2014 | 686 | 0.090 |
Why?
|
Telemetry | 1 | 2012 | 205 | 0.090 |
Why?
|
Mental Disorders | 5 | 2019 | 6600 | 0.090 |
Why?
|
Ovulation | 1 | 2011 | 189 | 0.090 |
Why?
|
Brain Diseases | 2 | 2011 | 1563 | 0.090 |
Why?
|
Critical Care | 3 | 2018 | 2647 | 0.090 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 2016 | 2408 | 0.090 |
Why?
|
Mental Recall | 1 | 2016 | 1205 | 0.090 |
Why?
|
Speech Perception | 3 | 1991 | 489 | 0.090 |
Why?
|
Combined Modality Therapy | 2 | 2019 | 8642 | 0.090 |
Why?
|
Autonomic Pathways | 1 | 2009 | 30 | 0.090 |
Why?
|
Electrocardiography | 3 | 2015 | 6442 | 0.090 |
Why?
|
Benzodiazepines | 1 | 2015 | 1101 | 0.090 |
Why?
|
Linear Models | 1 | 2019 | 5952 | 0.080 |
Why?
|
Emergency Medical Services | 3 | 2010 | 1917 | 0.080 |
Why?
|
Arousal | 1 | 2015 | 1165 | 0.080 |
Why?
|
Breast Neoplasms | 1 | 2016 | 20822 | 0.080 |
Why?
|
Brain Mapping | 3 | 2014 | 6669 | 0.080 |
Why?
|
Contraceptives, Oral, Combined | 1 | 2009 | 113 | 0.080 |
Why?
|
Estradiol | 3 | 2011 | 2020 | 0.080 |
Why?
|
Phonetics | 2 | 1991 | 206 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1797 | 0.080 |
Why?
|
Plastics | 1 | 2008 | 123 | 0.080 |
Why?
|
United States Food and Drug Administration | 1 | 2016 | 1584 | 0.080 |
Why?
|
Biological Clocks | 1 | 2010 | 321 | 0.080 |
Why?
|
Checklist | 1 | 2015 | 833 | 0.080 |
Why?
|
Affect | 1 | 2015 | 1476 | 0.080 |
Why?
|
Internship and Residency | 2 | 2023 | 5788 | 0.080 |
Why?
|
Biomedical Research | 1 | 2023 | 3309 | 0.070 |
Why?
|
Sudden Infant Death | 1 | 2010 | 291 | 0.070 |
Why?
|
Receptors, Opioid, mu | 1 | 2008 | 182 | 0.070 |
Why?
|
Developmental Disabilities | 1 | 2016 | 1456 | 0.070 |
Why?
|
Incidence | 3 | 2017 | 20947 | 0.070 |
Why?
|
Infant | 3 | 2016 | 35136 | 0.070 |
Why?
|
Telencephalon | 1 | 1987 | 142 | 0.070 |
Why?
|
Ventricular Fibrillation | 1 | 2009 | 538 | 0.070 |
Why?
|
Plant Preparations | 1 | 2007 | 94 | 0.070 |
Why?
|
Action Potentials | 1 | 2013 | 1806 | 0.070 |
Why?
|
Electrodes | 1 | 2008 | 619 | 0.070 |
Why?
|
Corpus Callosum | 1 | 2011 | 737 | 0.070 |
Why?
|
Speech Disorders | 1 | 1987 | 189 | 0.070 |
Why?
|
Concept Formation | 1 | 1987 | 158 | 0.070 |
Why?
|
Aromatase Inhibitors | 1 | 2010 | 491 | 0.070 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2011 | 719 | 0.070 |
Why?
|
Electric Countershock | 1 | 2009 | 534 | 0.070 |
Why?
|
Benzhydryl Compounds | 1 | 2012 | 845 | 0.070 |
Why?
|
Diffusion Tensor Imaging | 1 | 2016 | 2305 | 0.070 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2008 | 317 | 0.070 |
Why?
|
Aphasia, Wernicke | 3 | 1991 | 19 | 0.070 |
Why?
|
Craniotomy | 1 | 2010 | 729 | 0.070 |
Why?
|
Skull | 1 | 2010 | 813 | 0.060 |
Why?
|
Neuroprotective Agents | 1 | 2012 | 941 | 0.060 |
Why?
|
Carbamazepine | 3 | 2016 | 229 | 0.060 |
Why?
|
Telemedicine | 1 | 2022 | 2872 | 0.060 |
Why?
|
Child | 9 | 2019 | 77709 | 0.060 |
Why?
|
Aphasia, Broca | 3 | 1991 | 50 | 0.060 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2005 | 295 | 0.060 |
Why?
|
Neural Pathways | 1 | 2016 | 2972 | 0.060 |
Why?
|
Encephalitis | 1 | 2008 | 423 | 0.060 |
Why?
|
Nitriles | 1 | 2010 | 956 | 0.060 |
Why?
|
Phytotherapy | 1 | 2007 | 298 | 0.060 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2008 | 546 | 0.060 |
Why?
|
Triazoles | 1 | 2010 | 911 | 0.060 |
Why?
|
Cohort Studies | 9 | 2019 | 40561 | 0.060 |
Why?
|
Testosterone | 3 | 2010 | 2420 | 0.060 |
Why?
|
Morphine | 1 | 2008 | 657 | 0.060 |
Why?
|
Plethysmography | 2 | 2014 | 180 | 0.060 |
Why?
|
Hypogonadism | 1 | 2010 | 799 | 0.060 |
Why?
|
Child, Preschool | 3 | 2016 | 41006 | 0.060 |
Why?
|
Heart Conduction System | 1 | 2009 | 1047 | 0.060 |
Why?
|
Regression Analysis | 1 | 2013 | 6459 | 0.060 |
Why?
|
Age Distribution | 1 | 2009 | 2902 | 0.060 |
Why?
|
Boston | 1 | 2016 | 9313 | 0.060 |
Why?
|
Frontal Lobe | 1 | 2009 | 1406 | 0.060 |
Why?
|
Language | 1 | 2012 | 1471 | 0.060 |
Why?
|
Hospitals, Veterans | 1 | 2005 | 404 | 0.060 |
Why?
|
Predictive Value of Tests | 3 | 2018 | 15076 | 0.050 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2005 | 548 | 0.050 |
Why?
|
Meningioma | 1 | 2012 | 1209 | 0.050 |
Why?
|
Meningeal Neoplasms | 1 | 2012 | 1241 | 0.050 |
Why?
|
Syncope | 1 | 2005 | 429 | 0.050 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2009 | 1534 | 0.050 |
Why?
|
Cognition | 1 | 2019 | 6770 | 0.050 |
Why?
|
Primary Prevention | 1 | 2009 | 1167 | 0.050 |
Why?
|
Nurses | 1 | 2011 | 2461 | 0.050 |
Why?
|
Pregnancy Complications | 1 | 2016 | 2861 | 0.050 |
Why?
|
Severity of Illness Index | 3 | 2018 | 15540 | 0.050 |
Why?
|
Time Factors | 6 | 2017 | 40075 | 0.050 |
Why?
|
Biopsy | 1 | 2013 | 6756 | 0.050 |
Why?
|
Neuropsychological Tests | 5 | 2019 | 6993 | 0.050 |
Why?
|
Gonadal Steroid Hormones | 1 | 2005 | 712 | 0.050 |
Why?
|
Steroids | 1 | 2006 | 930 | 0.050 |
Why?
|
Maternal Exposure | 1 | 2008 | 961 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2018 | 21746 | 0.050 |
Why?
|
Risk Factors | 4 | 2020 | 72290 | 0.050 |
Why?
|
Cerebrovascular Disorders | 1 | 1987 | 1504 | 0.050 |
Why?
|
Cannabis | 1 | 2007 | 439 | 0.050 |
Why?
|
Health Surveys | 1 | 2010 | 4037 | 0.050 |
Why?
|
Depression | 2 | 2019 | 7766 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2015 | 19905 | 0.040 |
Why?
|
Pilot Projects | 3 | 2019 | 8324 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2020 | 8037 | 0.040 |
Why?
|
Androgens | 1 | 2006 | 1281 | 0.040 |
Why?
|
United States | 5 | 2017 | 69872 | 0.040 |
Why?
|
Memory Disorders | 2 | 2008 | 1184 | 0.040 |
Why?
|
Acute Disease | 1 | 2009 | 7149 | 0.040 |
Why?
|
Pregnancy | 3 | 2016 | 29144 | 0.040 |
Why?
|
Aging | 2 | 2015 | 8664 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2023 | 5078 | 0.040 |
Why?
|
Double-Blind Method | 4 | 2016 | 12026 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2013 | 6234 | 0.040 |
Why?
|
Neurotransmitter Agents | 1 | 2001 | 647 | 0.040 |
Why?
|
Speech | 1 | 2022 | 540 | 0.040 |
Why?
|
Preoperative Care | 1 | 2006 | 2250 | 0.040 |
Why?
|
Disease Progression | 1 | 2013 | 13284 | 0.040 |
Why?
|
Meningitis | 1 | 2018 | 216 | 0.040 |
Why?
|
Switzerland | 1 | 2016 | 255 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2023 | 906 | 0.030 |
Why?
|
Age Factors | 4 | 2017 | 18370 | 0.030 |
Why?
|
Dysphonia | 1 | 2018 | 144 | 0.030 |
Why?
|
Phenytoin | 2 | 2006 | 197 | 0.030 |
Why?
|
Probability | 1 | 2021 | 2505 | 0.030 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2019 | 260 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 5 | 2013 | 35421 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2009 | 12354 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2000 | 969 | 0.030 |
Why?
|
Reaction Time | 2 | 2019 | 2097 | 0.030 |
Why?
|
Neurons | 1 | 2013 | 9338 | 0.030 |
Why?
|
Observation | 1 | 2015 | 312 | 0.030 |
Why?
|
Forecasting | 1 | 2022 | 2951 | 0.030 |
Why?
|
Area Under Curve | 1 | 2017 | 1654 | 0.030 |
Why?
|
Electrodes, Implanted | 2 | 2009 | 824 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2019 | 2886 | 0.030 |
Why?
|
New Zealand | 1 | 2013 | 355 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2309 | 0.030 |
Why?
|
Anovulation | 1 | 2011 | 58 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2020 | 25043 | 0.020 |
Why?
|
Paired-Associate Learning | 1 | 1991 | 52 | 0.020 |
Why?
|
Logistic Models | 1 | 2006 | 13408 | 0.020 |
Why?
|
Minority Groups | 1 | 2019 | 1223 | 0.020 |
Why?
|
Attention | 2 | 2019 | 2400 | 0.020 |
Why?
|
Israel | 1 | 2013 | 796 | 0.020 |
Why?
|
Child Abuse | 1 | 2019 | 1030 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2023 | 2291 | 0.020 |
Why?
|
Attitude to Health | 1 | 2000 | 2052 | 0.020 |
Why?
|
Algorithms | 1 | 2011 | 13881 | 0.020 |
Why?
|
Oximetry | 1 | 2014 | 471 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2016 | 2029 | 0.020 |
Why?
|
Wakefulness | 1 | 2017 | 1245 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2016 | 10943 | 0.020 |
Why?
|
Australia | 1 | 2013 | 1170 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2000 | 2046 | 0.020 |
Why?
|
Inpatients | 1 | 2022 | 2518 | 0.020 |
Why?
|
Curriculum | 1 | 2023 | 3605 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2000 | 2278 | 0.020 |
Why?
|
Encephalitis, Varicella Zoster | 1 | 2008 | 9 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2005 | 4258 | 0.020 |
Why?
|
Anomia | 1 | 1988 | 14 | 0.020 |
Why?
|
Dyslexia, Acquired | 1 | 1988 | 14 | 0.020 |
Why?
|
Psychotropic Drugs | 1 | 2014 | 894 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2014 | 950 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 2010 | 552 | 0.020 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2008 | 212 | 0.020 |
Why?
|
Brain Abscess | 1 | 2008 | 118 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1504 | 0.020 |
Why?
|
Speech Production Measurement | 1 | 1987 | 98 | 0.020 |
Why?
|
Androstanes | 1 | 2006 | 21 | 0.020 |
Why?
|
Scalp | 1 | 2009 | 380 | 0.020 |
Why?
|
Europe | 1 | 2013 | 3339 | 0.020 |
Why?
|
Confusion | 1 | 2008 | 275 | 0.020 |
Why?
|
Speech Acoustics | 1 | 1987 | 151 | 0.020 |
Why?
|
Meningitis, Bacterial | 1 | 2008 | 218 | 0.020 |
Why?
|
Enzyme Induction | 1 | 2006 | 475 | 0.020 |
Why?
|
Odds Ratio | 1 | 2019 | 9849 | 0.020 |
Why?
|
Neuronal Plasticity | 1 | 2014 | 1422 | 0.020 |
Why?
|
Biological Availability | 1 | 2006 | 397 | 0.020 |
Why?
|
Dehydroepiandrosterone | 1 | 2006 | 252 | 0.020 |
Why?
|
Patient Discharge | 1 | 2018 | 3313 | 0.020 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2006 | 187 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3508 | 0.020 |
Why?
|
Drug Interactions | 1 | 2009 | 1460 | 0.010 |
Why?
|
Auditory Perception | 1 | 2008 | 569 | 0.010 |
Why?
|
Voice | 1 | 1987 | 259 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2016 | 3528 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2010 | 2373 | 0.010 |
Why?
|
Eicosapentaenoic Acid | 1 | 2008 | 582 | 0.010 |
Why?
|
Marijuana Smoking | 1 | 2007 | 253 | 0.010 |
Why?
|
Length of Stay | 1 | 2016 | 6309 | 0.010 |
Why?
|
Luteinizing Hormone | 1 | 2005 | 869 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2010 | 14722 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 3 | 2013 | 20129 | 0.010 |
Why?
|
Cerebral Palsy | 1 | 2007 | 459 | 0.010 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2019 | 4266 | 0.010 |
Why?
|
Age of Onset | 1 | 2008 | 3271 | 0.010 |
Why?
|
Docosahexaenoic Acids | 1 | 2008 | 875 | 0.010 |
Why?
|
Syndrome | 1 | 1987 | 3251 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8340 | 0.010 |
Why?
|
Hypertension | 1 | 2000 | 8480 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2010 | 6489 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2014 | 4245 | 0.010 |
Why?
|
Prognosis | 1 | 2000 | 29063 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10397 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 7913 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6171 | 0.010 |
Why?
|
Down-Regulation | 1 | 2005 | 3002 | 0.010 |
Why?
|
Critical Illness | 1 | 2010 | 2670 | 0.010 |
Why?
|
Amygdala | 1 | 2005 | 1315 | 0.010 |
Why?
|
Base Sequence | 1 | 2008 | 12797 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2008 | 18111 | 0.010 |
Why?
|
Brain Injuries | 1 | 2005 | 2025 | 0.010 |
Why?
|
Hippocampus | 1 | 2005 | 3675 | 0.010 |
Why?
|
Registries | 1 | 2008 | 8089 | 0.010 |
Why?
|
Mass Screening | 1 | 2007 | 5255 | 0.010 |
Why?
|
Research Design | 1 | 2007 | 5987 | 0.010 |
Why?
|
Body Mass Index | 1 | 2009 | 12720 | 0.010 |
Why?
|
Brain Damage, Chronic | 1 | 1991 | 265 | 0.010 |
Why?
|